Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Malarial parasites hide during the dry season!

SA-Encrusted Seed Restores Grass species

Optomec releases cost-effective, efficient 3D bio-printer

Malarial parasites hide during the dry season!
  • BiotechToday
  • World

Malarial parasites hide during the dry season!

bioxone October 31, 2020October 30, 2020

Parnad Basu, Amity University Kolkata

Among the five species of Plasmodium (P. falciparum, P. malariae, P. vivax, P. ovale, and P. knowlesi.) that cause malaria, P. falciparum can be fatal. On one hand, it can cause liver failure to coma, on the other hand, it is somewhat resistant to the malarial drugs. The thing that kept scientists thinking is how does it survive the dry season between two wet seasons. The dry season is when the virulence of P. falciparum dips down, and the wet season is when it affects people. So why do we see a surge in malaria infection in the wet season typically?

To uncover the mystery behind this a team of scientists conducted a study on Malian where each year a huge number of peoples die due to malaria. In the wet season, the malarial parasite disappears from blood circulation by adhering to the blood vessels wall inside the red blood cell. Malarial parasites use VSA (variant surface antigens) to stick to the blood vessels. Doing so, they easily evade the innate immune clearance mechanisms in the spleen. But the study shows that in the dry season, the adhesion qualities of the parasites lack. Because of this, only a few malarial parasites stick to the blood vessels whereas the other parasites face splenic clearance. This helps the parasites to be present in the host body without triggering the immune response. When the next wet season comes these parasites transform into gametocytes which then gets ingested by mosquitoes and carried to a new host.

In the dry season, the host who carries dormant malarial parasites is asymptomatic but sometimes a slight fever was noted. Mosquito saliva and human allergies due to mosquito saliva trigger this transformation from parasites to gametocytes. That being said, how mosquito bite alters the development of the parasite in the human host to favour enhanced development and transmission to mosquitoes is still unknown.

Also read: SA-Encrusted Seed Restores Grass species

Reference:  DOI: 10.1038/s41591-020-1084-0

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged blood infection falciparum falciparum malaria gametocytes human allergens Malaria malaria is caused by malaria mosquito malaria symptoms Variant Surface Antigens

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Optomec releases cost-effective, efficient 3D bio-printer

bioxone October 31, 2020

We are already known to the wonders of three-dimensional bioprinting (3D printing). The technology majorly involves techniques to combine cells, growth factors, and biomaterial to fabricate biomedical parts that maximally imitate natural tissue characteristics. 3D bioprinting involves layer after layer deposition of biomaterials like bioinks to create tissue-like structure, which can be used in tissue […]

Optomec

Related Post

  • BiotechToday
  • India

Coviself: Covid-19 home testing kit approved by ICMR

bioxone May 20, 2021May 20, 2021

Aakancha Shaw, St. Xavier’s College, Kolkata On Wednesday, the ICMR issued an advisory for the use of a home testing kit for Covid-19. This home testing kit is the rapid antigen testing kit developed and validated by Mylab Discovery Solutions, named “Coviself Covid19 OTC Antigen LF device”. Drugs Controller General of India (DCGI) has also […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

How statins lower the death rate in COVID-19 patients

bioxone July 19, 2021July 19, 2021

Saakshi Bangera, DY Patil School of Biotechnology and Bioinformatics Despite the improving research methodologies and treatments, COVID-19 continues to spread, causing deaths and morbidity across the world. It has been found that statins can potentially decrease the severity of COVID-19. However, this field has been less researched due to limited size and region-centred studies.  Statins […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Moderna requests emergency authorization from FDA for mRNA – 1273

bioxone December 1, 2020December 1, 2020

Prama Ghosh, Amity University Kolkata The Cambridge, Massachusetts – based Biotech Company, Moderna asked for emergency authorization from the U.S. Food and Drug Administration to use its COVID – 19 vaccines, mRNA – 1273, after receiving confirmation about its safety and efficacy on Monday. According to a new study, the shots offer a strong protection […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy